214 related articles for article (PubMed ID: 32986699)
1. 2020 Review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift.
Sullivan RP; Marshall CS; Anstey NM; Ward L; Currie BJ
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008659. PubMed ID: 32986699
[TBL] [Abstract][Full Text] [Related]
2. Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigm.
Pitman MC; Luck T; Marshall CS; Anstey NM; Ward L; Currie BJ
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003586. PubMed ID: 25811783
[TBL] [Abstract][Full Text] [Related]
3. Oral eradication therapy for melioidosis: Important but not without risks.
Sullivan RP; Ward L; Currie BJ
Int J Infect Dis; 2019 Mar; 80():111-114. PubMed ID: 30659921
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting clinical outcomes in the management of melioidosis in Singapore: a 16-year case series.
Chien JM; Saffari SE; Tan AL; Tan TT
BMC Infect Dis; 2018 Sep; 18(1):482. PubMed ID: 30257647
[TBL] [Abstract][Full Text] [Related]
5. Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters.
Huffam S; Jacups SP; Kittler P; Currie BJ
Trop Med Int Health; 2004 Jun; 9(6):715-7. PubMed ID: 15189462
[TBL] [Abstract][Full Text] [Related]
6. Burkholderia pseudomallei: the unbeatable foe?
Leelarasamee A
Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):410-5. PubMed ID: 9886137
[TBL] [Abstract][Full Text] [Related]
7. Two patients with recurrent melioidosis after prolonged antibiotic therapy.
Silbermann MH; Gyssens IC; Endtz HP; Kuijper EJ; van der Meer JT
Scand J Infect Dis; 1997; 29(2):199-201. PubMed ID: 9181661
[TBL] [Abstract][Full Text] [Related]
8. A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis.
Limmathurotsakul D; Chaowagul W; Chantratita N; Wuthiekanun V; Biaklang M; Tumapa S; White NJ; Day NP; Peacock SJ
PLoS Negl Trop Dis; 2008; 2(10):e327. PubMed ID: 18958279
[TBL] [Abstract][Full Text] [Related]
9. Melioidosis Causing Critical Illness: A Review of 24 Years of Experience From the Royal Darwin Hospital ICU.
Stephens DP; Thomas JH; Ward LM; Currie BJ
Crit Care Med; 2016 Aug; 44(8):1500-5. PubMed ID: 26963328
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
Jenney AW; Lum G; Fisher DA; Currie BJ
Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
[TBL] [Abstract][Full Text] [Related]
11. Osteomyelitis caused by Burkholderia pseudomallei: relapse six years after pulmonary infection.
Vollmar P; Zange S; Fieser N; Riehm J; Zöller L; Thoma B
Clin Lab; 2014; 60(9):1565-7. PubMed ID: 25291954
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.
Currie BJ; Ward L; Cheng AC
PLoS Negl Trop Dis; 2010 Nov; 4(11):e900. PubMed ID: 21152057
[TBL] [Abstract][Full Text] [Related]
13. Melioidosis: acute and chronic disease, relapse and re-activation.
Currie BJ; Fisher DA; Anstey NM; Jacups SP
Trans R Soc Trop Med Hyg; 2000; 94(3):301-4. PubMed ID: 10975006
[TBL] [Abstract][Full Text] [Related]
14. Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare.
Sarovich DS; Ward L; Price EP; Mayo M; Pitman MC; Baird RW; Currie BJ
J Clin Microbiol; 2014 Feb; 52(2):650-3. PubMed ID: 24478504
[TBL] [Abstract][Full Text] [Related]
15. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis.
Chaowagul W; Chierakul W; Simpson AJ; Short JM; Stepniewska K; Maharjan B; Rajchanuvong A; Busarawong D; Limmathurotsakul D; Cheng AC; Wuthiekanun V; Newton PN; White NJ; Day NP; Peacock SJ
Antimicrob Agents Chemother; 2005 Oct; 49(10):4020-5. PubMed ID: 16189075
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes of bacteraemic melioidosis in a teaching hospital in a northeastern state of Malaysia: a five-year review.
Deris ZZ; Hasan H; Siti Suraiya MN
J Infect Dev Ctries; 2010 Aug; 4(7):430-5. PubMed ID: 20818090
[TBL] [Abstract][Full Text] [Related]
17. A proposed scoring system for predicting mortality in melioidosis.
Cheng AC; Jacups SP; Anstey NM; Currie BJ
Trans R Soc Trop Med Hyg; 2003; 97(5):577-81. PubMed ID: 15307431
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review.
Keragala KARK; Gunathilaka MGRSS; Senevirathna RMISK; Jayaweera JAAS
Ann Clin Microbiol Antimicrob; 2023 Aug; 22(1):74. PubMed ID: 37592339
[TBL] [Abstract][Full Text] [Related]
19. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
20. Fatal melioidosis in a tourist returning from Thailand.
Wilks D; Jacobson SK; Lever AM; Farrington M
J Infect; 1994 Jul; 29(1):87-90. PubMed ID: 7525733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
